[1]
“MALIGNANT MIXED MULLERIAN TUMOR OF THE UTERUS: A COMPLICATION OF TAMOXIFEN THERAPY FOR BREAST CARCINOMA”, Int J of Biomed & Adv Res, vol. 3, no. 5, pp. 339–342, Jun. 2012, doi: 10.7439/ijbar.v3i5.474.